191 related articles for article (PubMed ID: 26582563)
1. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
[TBL] [Abstract][Full Text] [Related]
2. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
Sathe P; Saka R; Kommineni N; Raza K; Khan W
Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
[TBL] [Abstract][Full Text] [Related]
3. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs.
Shah PP; Desai PR; Patel AR; Singh MS
Biomaterials; 2012 Feb; 33(5):1607-17. PubMed ID: 22118820
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-Loaded Nanostructured Lipid Carrier Gel Alleviates Imiquimod-Induced Psoriasis by Moderating Inflammation: Formulation, Optimization, Characterization, In-Vitro and In-Vivo Studies.
Agrawal YO; Mahajan UB; Mahajan HS; Ojha S
Int J Nanomedicine; 2020; 15():4763-4778. PubMed ID: 32753865
[TBL] [Abstract][Full Text] [Related]
5. Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Somagoni J; Boakye CH; Godugu C; Patel AR; Mendonca Faria HA; Zucolotto V; Singh M
PLoS One; 2014; 9(12):e115952. PubMed ID: 25546392
[TBL] [Abstract][Full Text] [Related]
6. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
7. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.
Doppalapudi S; Jain A; Chopra DK; Khan W
Eur J Pharm Sci; 2017 Jan; 96():515-529. PubMed ID: 27777066
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.
Jain A; Doppalapudi S; Domb AJ; Khan W
J Control Release; 2016 Dec; 243():132-145. PubMed ID: 27725194
[TBL] [Abstract][Full Text] [Related]
9. α-MSH-stimulated tolerogenic dendritic cells induce functional regulatory T cells and ameliorate ongoing skin inflammation.
Auriemma M; Brzoska T; Klenner L; Kupas V; Goerge T; Voskort M; Zhao Z; Sparwasser T; Luger TA; Loser K
J Invest Dermatol; 2012 Jul; 132(7):1814-24. PubMed ID: 22418871
[TBL] [Abstract][Full Text] [Related]
10. Improved topical delivery of tacrolimus: A novel composite hydrogel formulation for the treatment of psoriasis.
Gabriel D; Mugnier T; Courthion H; Kranidioti K; Karagianni N; Denis MC; Lapteva M; Kalia Y; Möller M; Gurny R
J Control Release; 2016 Nov; 242():16-24. PubMed ID: 27639683
[TBL] [Abstract][Full Text] [Related]
11. Topical drug delivery by a polymeric nanosphere gel: Formulation optimization and in vitro and in vivo skin distribution studies.
Batheja P; Sheihet L; Kohn J; Singer AJ; Michniak-Kohn B
J Control Release; 2011 Jan; 149(2):159-67. PubMed ID: 20950659
[TBL] [Abstract][Full Text] [Related]
12. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
Chandra A; Aggarwal G; Manchanda S; Narula A
Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
[TBL] [Abstract][Full Text] [Related]
13. Dual roles of TPGS based microemulsion for tacrolimus: Enhancing the percutaneous delivery and anti-psoriatic efficacy.
Wan T; Pan J; Long Y; Yu K; Wang Y; Pan W; Ruan W; Qin M; Wu C; Xu Y
Int J Pharm; 2017 Aug; 528(1-2):511-523. PubMed ID: 28629978
[TBL] [Abstract][Full Text] [Related]
14. Anti-psoriatic potential of Solanum xanthocarpum stem in Imiquimod-induced psoriatic mice model.
Parmar KM; Itankar PR; Joshi A; Prasad SK
J Ethnopharmacol; 2017 Feb; 198():158-166. PubMed ID: 28052238
[TBL] [Abstract][Full Text] [Related]
15. Gel-like TPGS-Based Microemulsions for Imiquimod Dermal Delivery: Role of Mesostructure on the Uptake and Distribution into the Skin.
Telò I; Favero ED; Cantù L; Frattini N; Pescina S; Padula C; Santi P; Sonvico F; Nicoli S
Mol Pharm; 2017 Oct; 14(10):3281-3289. PubMed ID: 28825487
[TBL] [Abstract][Full Text] [Related]
16. Chronic delivery of α-melanocyte-stimulating hormone in rat hypothalamus using albumin-alginate microparticles: effects on food intake and body weight.
Lucas N; Legrand R; Breton J; Déchelotte P; Edwards-Lévy F; Fetissov SO
Neuroscience; 2015 Apr; 290():445-53. PubMed ID: 25637491
[TBL] [Abstract][Full Text] [Related]
17. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
[TBL] [Abstract][Full Text] [Related]
18. Fenoldopam mesylate for treating psoriasis: A new indication for an old drug.
Doppalapudi S; Jain A; Khan W; Domb AJ
Int J Pharm; 2020 Jan; 573():118726. PubMed ID: 31715365
[TBL] [Abstract][Full Text] [Related]
19. Preparation and In Vivo Evaluation of Rosmarinic Acid-Loaded Transethosomes After Percutaneous Application on a Psoriasis Animal Model.
Rodríguez-Luna A; Talero E; Ávila-Román J; Romero AMF; Rabasco AM; Motilva V; González-Rodríguez ML
AAPS PharmSciTech; 2021 Mar; 22(3):103. PubMed ID: 33712964
[TBL] [Abstract][Full Text] [Related]
20. Microemulsions mediated effective delivery of methotrexate hydrogel: more than a tour de force in psoriasis therapeutics.
Amarji B; Garg NK; Singh B; Katare OP
J Drug Target; 2016; 24(2):147-60. PubMed ID: 26204326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
